EcoDrugPlus

Adrenoceptor Alpha 2a

Ensembl ID : ENSBGRG00000018331
Gene Symbol: ADRA2A
1 Cross references
227 Possible Orthologues:

Adrenoceptor Alpha 2b

Ensembl ID : ENSBGRG00000026781
Gene Symbol: ADRA2B
1 Cross references
222 Possible Orthologues:

Adrenoceptor Beta 1

Ensembl ID : ENSBGRG00000024992
Gene Symbol: ADRB1
1 Cross references
163 Possible Orthologues:

Adrenoceptor Beta 2

Ensembl ID : ENSBGRG00000018281
Gene Symbol: ADRB2
1 Cross references
265 Possible Orthologues:

Adrenoceptor Beta 3

Ensembl ID : ENSBGRG00000018794
Gene Symbol: ADRB3
1 Cross references
218 Possible Orthologues:

Advanced Glycosylation End-Product Specific Receptor

Ensembl ID : ENSBGRG00000016340
Gene Symbol: AGER
1 Cross references
170 Possible Orthologues:

Alcohol Dehydrogenase 5 (Class Iii), Chi Polypeptide

Ensembl ID : ENSBGRG00000001695
Gene Symbol: ADH5
1 Cross references
405 Possible Orthologues:

Alpha Glucosidase

Ensembl ID : ENSBGRG00000021492
Gene Symbol: GAA
1 Cross references
233 Possible Orthologues:

Amine Oxidase Copper Containing 1

Ensembl ID : ENSBGRG00000004317
Gene Symbol: AOC1
1 Cross references
233 Possible Orthologues:

Amyloid P Component, Serum

Ensembl ID : ENSBGRG00000012713
Gene Symbol: APCS
1 Cross references
402 Possible Orthologues:

Amyloid Beta Precursor Protein

Ensembl ID : ENSBGRG00000000062
Gene Symbol: APP
1 Cross references
279 Possible Orthologues:

Androgen Receptor

Ensembl ID : ENSBGRG00000010012
Gene Symbol: AR
1 Cross references
277 Possible Orthologues:

Select Keywords:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).